Easing the Burden of Chronic Cough: Improving Care Coordination and Examining Emerging Options

Released On
December 31, 2020

Expires On
December 30, 2021

Media Type
Internet

Completion Time
45 minutes

Specialty
Allergy & Immunology

Scroll to the Bottom of this Information to Begin this Course

This continuing medical education activity is provided by

This activity is supported by an educational grant from Merck & Co., Inc.

Credit Available

  • Physicians — maximum of 0.75 AMA PRA Category 1 Credit(s)

All other health care professionals completing this course will be issued a statement of participation.

Target Audience

The intended audience for this activity is allergists, immunologists, and other health care professionals involved in the management of patients with chronic cough.

Program Overview

Chronic cough lasting more than 8 weeks impacts up to 13% of the US population. While chronic cough may be associated with any number of pulmonary or extrapulmonary conditions, 70% of patients with chronic cough experience at least 3 clinical encounters to obtain a diagnosis and 53% remain undiagnosed. Additionally, over half of patients who receive treatment note that their symptoms remain uncontrolled, significantly affecting daily activities, sleep, and quality of life. With new treatments on the horizon for managing chronic cough, it is imperative that clinicians have a mechanistic understanding of chronic cough and are able to identify patients who may benefit from emerging therapies. In this educational activity, experts will review current unmet needs and underlying mechanisms in chronic cough, guidelines for assessment and management, and the latest data on emerging treatment options to improve the quality of life for patients with refractory chronic cough. Faculty will also discuss strategies for applying best practices using a clinical case example.

Learning Objectives

Upon completion of this activity, participants should be better able to:

  • Examine common challenges associated with healthcare journey of patients with chronic cough and the burden on quality of life.
  • Assess the latest mechanistic understanding regarding the causes of chronic cough and implications for treatment.
  • Evaluate the latest clinical evidence regarding emerging treatment strategies for patients with chronic cough.

Activity Chair

Michael S. Blaiss, MD

Michael S. Blaiss, MD, FAAAI, FACAAI

Clinical Professor of Pediatrics
Medical College of Georgia at Augusta University
Executive Medical Director, American College of Allergy, Asthma, and Immunology
Augusta, GA

Faculty

Peter Dicpinigaitis, MD, FCCP

Peter Dicpinigaitis, MD, FCCP

Professor of Medicine, Albert Einstein College of Medicine
Division of Critical Care Medicine, Montefiore Medical Center
Director, Montefiore Cough Center
Bronx, NY

Alan B. Goldsobel, MD, FAAAI, FACAAI, CPI

Alan B. Goldsobel, MD, FAAAI, FACAAI, CPI

Allergy and Asthma Associates of Northern California
Adjunct Clinical Professor
Stanford University School of Medicine
Stanford, CA

Reviewer

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP

Accreditation Statement

Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation

Vindico Medical Education designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosures of Conflicts of Interest

In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all accredited providers are required to mitigate and disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of accredited content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the past 12 months with a commercial interest whose products or services are discussed in the accredited activity content over which the individual has control. Relationship information appears below.

Activity Chair and Faculty report the following relationship(s):

Michael S. Blaiss, MD, FAAAI, FACAAI

  • Consulting Fee: Bellus, Merck

Peter Dicpinigaitis, MD, FCCP

  • Consulting Fee: Bayer, Bellus, Merck, Shionogi

Alan B. Goldsobel, MD, FAAAI, FACAAI, CPI

  • Consulting Fee: Bellus, Merck
  • Contracted Research: Afferent, Bellus, Menlo Therapeutics, Merck, NeRRe

Reviewer reports the following relationship(s):

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP

  • No relevant financial relationships to disclose.

Vindico Medical Education staff report the following relationship(s):

No relevant financial relationships to disclose.

Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.

Instructions for Participation and Credit

There are no fees for participating and receiving CME credit for this enduring activity. To receive CME credit participants must:

  1. Read the objectives, answer the pretest questions, view the content, and complete the posttest.
  2. Achieve a satisfactory score is defined as by answering at least 2 of 3 of the posttest questions correctly.
  3. Submit the evaluation form.
If a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ Certificate. Certificates will be emailed to the participant.

 

Course Viewing Requirements

Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above

Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above

Disclosure of Unlabeled Use

The audience is advised that this continuing education activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage.

Copyright Statement

Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2020 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.

CME Questions?

Contact us at cme@vindicoCME.com